FY2024 EPS Estimates for ICON Public Raised by William Blair

ICON Public Limited (NASDAQ:ICLR) – Investment analysts at William Blair raised their FY2024 EPS estimates for ICON Public in a report released on Wednesday, January 15th. William Blair analyst M. Smock now expects that the medical research company will earn $13.55 per share for the year, up from their prior estimate of $13.40. William Blair currently has a “Outperform” rating on the stock. The consensus estimate for ICON Public’s current full-year earnings is $13.44 per share. William Blair also issued estimates for ICON Public’s FY2025 earnings at $13.33 EPS.

Several other equities research analysts have also recently weighed in on the stock. Barclays reduced their price target on shares of ICON Public from $330.00 to $275.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Baird R W downgraded shares of ICON Public from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 24th. The Goldman Sachs Group reduced their price objective on ICON Public from $370.00 to $280.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Citigroup lowered their price objective on ICON Public from $300.00 to $290.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Finally, Leerink Partners restated an “outperform” rating and set a $255.00 price target (down previously from $270.00) on shares of ICON Public in a report on Tuesday, November 19th. Four equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, ICON Public presently has a consensus rating of “Moderate Buy” and an average target price of $287.00.

ICON Public Stock Performance

NASDAQ ICLR opened at $205.07 on Monday. The stock has a market capitalization of $16.92 billion, a PE ratio of 22.86, a P/E/G ratio of 1.48 and a beta of 1.20. ICON Public has a 1-year low of $183.38 and a 1-year high of $347.72. The business has a 50 day simple moving average of $209.29 and a two-hundred day simple moving average of $265.86. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.34 and a quick ratio of 1.34.

ICON Public (NASDAQ:ICLR) last released its quarterly earnings data on Wednesday, October 23rd. The medical research company reported $3.35 EPS for the quarter, missing the consensus estimate of $3.72 by ($0.37). ICON Public had a net margin of 9.00% and a return on equity of 11.91%. The company had revenue of $2.03 billion for the quarter, compared to the consensus estimate of $2.13 billion. During the same period last year, the company earned $3.10 EPS. The firm’s revenue for the quarter was down 1.2% on a year-over-year basis.

Institutional Investors Weigh In On ICON Public

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Park Place Capital Corp increased its stake in shares of ICON Public by 281.4% during the fourth quarter. Park Place Capital Corp now owns 225 shares of the medical research company’s stock valued at $47,000 after buying an additional 166 shares during the period. GAMMA Investing LLC raised its holdings in shares of ICON Public by 64.0% in the 4th quarter. GAMMA Investing LLC now owns 433 shares of the medical research company’s stock valued at $91,000 after purchasing an additional 169 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in shares of ICON Public by 39.2% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 394 shares of the medical research company’s stock worth $129,000 after purchasing an additional 111 shares during the period. Whittier Trust Co. of Nevada Inc. increased its holdings in ICON Public by 23.1% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 511 shares of the medical research company’s stock valued at $147,000 after buying an additional 96 shares during the period. Finally, First Horizon Advisors Inc. raised its stake in ICON Public by 33.9% in the third quarter. First Horizon Advisors Inc. now owns 597 shares of the medical research company’s stock worth $172,000 after buying an additional 151 shares in the last quarter. 95.61% of the stock is owned by institutional investors.

About ICON Public

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.